ATLANTA (EWTN News)—A pro-life group’s concerns that PepsiCo may be using aborted fetal cell lines for research and development of beverage flavor enhancers have prompted a shareholder to file a resolution asking PepsiCo to adopt a policy against such research.
In August 2010 PepsiCo entered into a four-year agreement with the company Senomyx to develop high-potency sweeteners for its beverages. PepsiCo is paying $30 million for the research and future royalties on PepsiCo products sold using the technology.
Most of Senomyx’s patents involve the aborted fetal cell line HEK-293, which originated in human embryonic kidneys.
The Largo, Fla.-based group Children of God for Life wrote both...READ MORE